Free Content No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics

Authors: de Hoon, J. N. J. M.1; Thijssen, H. H. W.1; Beysens, A. J. M. M.2; Van Bortel, L. M. A. B.1

Source: British Journal of Clinical Pharmacology, Volume 44, Number 4, October 1997 , pp. 399-401(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Aims To investigate the effect of omeprazole on the pharmacokinetics of R- and S-acenocoumarol and on their combined anticoagulant activity.

Methods Eight healthy male subjects completed a double-blind, randomized, placebo-controlled, two-way cross-over study. Subjects were given either omeprazole 40 mg or placebo once daily for 3 days. On day 2 of each study period, a single 10 mg oral dose of racemic acenocoumarol was administered and venous blood samples were collected for pharmacokinetic and pharmacodynamic assessments. A wash-out period of 2 weeks separated the two study periods.

Results The pharmacokinetics of R- and S-acenocoumarol (AUC 3016±221 and 233±14 ng ml−1 h, respectively) did not change after omeprazole (AUC 2929±256 and 220±18 ng ml−1 h, respectively). Anticoagulant activity (INRmax 1.7±0.1) was unaffected by co-administration of omeprazole (INRmax 1.7±0.1).

Conclusions The short-term intake of omeprazole does not affect acenocoumarol pharmacokinetics or pharmacodynamics. These data differ from the results of previous studies on the effect of omeprazole on warfarin, suggesting a different in vivo interaction profile of omeprazole on acenocoumarol than on warfarin. Drug interaction studies with oral anticoagulants should not be restricted to the use of warfarin.

Keywords: drug interaction; acenocoumarol; omeprazole; oral anticoagulants

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1365-2125.1997.00600.x

Affiliations: 1: Department of Pharmacology, Maastricht University, Cardiovascular Research Institute Maastricht, 2: Clinical Pharmacy, Academic Hospital Maastricht, The Netherlands

Publication date: 1997-10-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page